The molecular basis of congenital heart disease

Michael E Mitchell1, Tara L Sander, Denise B Klinkner

  • 1Department of Surgery, Division of Cardiothoracic Surgery, Medical College of Wisconsin, Children's Hospital of Wisconsin, and Children's Research Institute, Milwaukee, Wisconsin 53226, USA. MMitchell@chw.org

Insights

Congenital heart disease (CHD) affects 1% of births and is a leading cause of death. The exact causes of most CHD cases remain unknown, highlighting the need for further research into complex genetic and environmental factors.

Area of Science:

  • Cardiovascular Science
  • Developmental Biology
  • Genetics

Background:

  • Congenital heart disease (CHD) impacts approximately 1% of live births, representing the primary cause of mortality from birth defects in the U.S.
  • Despite advancements in understanding cardiac development, the underlying etiology for most CHD cases remains elusive.
  • Known causal factors like maternal diabetes, drug exposure, and specific gene variants account for only a small proportion of cases.

Purpose of the Study:

  • To explore the complex etiology of congenital heart disease (CHD).
  • To address the challenges in elucidating the molecular basis of CHD.
  • To investigate the interplay of genetic and environmental factors in abnormal cardiac development.

Main Methods:

  • Review of existing literature on CHD etiology.
  • Analysis of genetic and environmental risk factors associated with CHD.
  • Examination of recurrence risks and variable expressivity in familial cases.
  • Consideration of chromosomal abnormalities and their incomplete association with CHD.

Main Results:

  • The fundamental causes of the majority of congenital heart disease (CHD) cases are currently unknown.
  • CHD etiology is complex, not explained by simple Mendelian genetics, suggesting a multifactorial origin.
  • Genetic and environmental factors likely interact to cause abnormal cardiac development.

Conclusions:

  • Elucidating the molecular basis of CHD is challenging due to its complex etiology.
  • Further research is crucial to understand the interplay of genetic predispositions and environmental influences in CHD development.
  • The molecular basis of CHD remains an active and evolving area of scientific inquiry.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.